Leadership Transition at Arrowhead Pharmaceuticals' Board

TipRanksDec 18 06:34 ET

In the Wake of Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Latest US$112m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions

Simply Wall StDec 17 12:16 ET

B.Riley Financial Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Announces Target Price $51

Moomoo NewsDec 12 08:31 ET · Ratings

B. Riley Lowers Price Target on Arrowhead Pharmaceuticals to $51 From $55, Keeps Buy Rating

MT NewswiresDec 12 07:54 ET · Ratings

Arrowhead Pharmaceuticals: Positioned for Growth With Strategic Partnerships and SiRNA Advancements

TipRanksDec 12 07:35 ET

Chardan Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsDec 11 21:31 ET · Ratings